Market Place
Sourcing Support
Dabur India posts Q4 FY25 consolidated PAT at Rs. 320.13 Cr
12 May 2025 //
INDPHARMAPOST
Dabur appoints Sriram Padmanabhan as Head of Health Care Business
14 Apr 2025 //
INDPHARMAPOST
Dabur Q1 FY25 consolidated net profit up 8% at Rs 500 Cr
01 Aug 2024 //
INDIANPHARMAPOST
Dabur India updates on Q1 FY25
06 Jul 2024 //
INDIAPHARMAPOST
India`s Religare asked to seek regulatory nod for top investor raising stake
19 Jun 2024 //
REUTERS
Dabur India posts Q4 FY24 consolidated PAT at Rs. 349.53 Cr
04 May 2024 //
INDINPHARMAPOST
Dabur India`s two units dismissed as defendants in hair relaxer lawsuit in US
15 Nov 2023 //
REUTERS
Dabur India`s units face lawsuits in US, Canada alleging products caused cancer
19 Oct 2023 //
REUTERS
Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr
03 Feb 2023 //
INDIAN PHARMA POST
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.